Dendritic Cells as Immunometabolic Regulatory Nodes in Diabetes: Molecular Mechanisms and Therapeutic Reprogramming
International Journal of Molecular Sciences · 06.07.2026 · 27 (13) · 6057
DOI: 10.3390/ijms27136057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2026. Verfasst von Fangfang Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China. Hauptthemen laut MEDLINE: Dendritic Cells, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central public welfare research institutes, the National Natural Science Foundation of China, Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus comprises a group of heterogeneous metabolic disorders characterized by persistent hyperglycemia, progressive β-cell dysfunction, and multi-organ complications. Although type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) have distinct pathogenic origins, both involve immune dysregulation, tissue stress, release of danger signals, and chronic inflammation. Dendritic cells (DCs), as antigen-presenting cells, integrate innate immune sensing, antigen presentation, cytokine production, T-cell regulation, and peripheral immune tolerance, placing them at a critical interface between autoimmunity and metabolic inflammation. In T1DM, DCs contribute to β-cell autoantigen presentation, tolerance breakdown, autoreactive T-cell activation, and insulitis amplification. In T2DM, DCs may contribute to adipose tissue inflammation, hepatic immunometabolic crosstalk, β-cell stress, vascular inflammation, and immune remodeling associated with diabetes-related complications. Here, we review the disease-specific roles of DC subsets in T1DM and T2DM and discuss shared molecular mechanisms, including pattern-recognition receptor signaling, metabolic reprogramming, inflammasome activation, cytokine networks, and the shift from immune tolerance to inflammation. We also evaluate therapeutic DC reprogramming strategies and their potential implications for targeted immunometabolic intervention in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- School of Traditional Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
ORCID-Profile: Xuan Yang
Förderung
- the Fundamental Research Funds for the Central public welfare research institutes
- the National Natural Science Foundation of China
- Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences
- Fundamental Research Funds for the Central public welfare research institutes
- National Natural Science Foundation of China
Zitieren
APA
Jin, F., Wu, W., Yang, X., Fan, X., Zhao, X., Liu, W., & Fan, X. (2026). Dendritic Cells as Immunometabolic Regulatory Nodes in Diabetes: Molecular Mechanisms and Therapeutic Reprogramming. International Journal of Molecular Sciences, 27(13), 6057. https://doi.org/10.3390/ijms27136057
Vancouver
Jin F, Wu W, Yang X, Fan X, Zhao X, Liu W, et al. Dendritic Cells as Immunometabolic Regulatory Nodes in Diabetes: Molecular Mechanisms and Therapeutic Reprogramming. International Journal of Molecular Sciences. 2026;27(13):6057. doi:10.3390/ijms27136057
BibTeX
@article{Jin2026,
author = {Jin, Fangfang and Wu, Weidong and Yang, Xuan and Fan, Xiang and Zhao, Xiaosen and Liu, Wei and Fan, Xinrong},
title = {Dendritic Cells as Immunometabolic Regulatory Nodes in Diabetes: Molecular Mechanisms and Therapeutic Reprogramming},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6057},
doi = {10.3390/ijms27136057}
}
EUVIMED